BCEL — Atreca Share News
0.000.00%
Last trade - 00:00Brief: Immunome To Acquire Antibody-Related Assets And Materials From Atreca
Brief: Atreca Says On Dec 19 Asset Sale And Other Transactions Contemplated By Agreement, Board Approved Liquidation And Dissolution Of Co
Brief: Atreca Q3 basic EPS USD -0.92
Brief: Atreca Announces Agreement To Terminate Lease And Departure Of CFO Herb Cross
Brief: Atreca Says On Sept 8, Co Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
U.S. RESEARCH ROUNDUP-Autodesk, Bill Holdings, Zoetis
U.S. RESEARCH ROUNDUP-Caci International, Cyberark Software, Ralph Lauren
Atreca Inc reports results for the quarter ended in June - Earnings Summary
Brief: Atreca Q2 basic EPS USD -0.49
Atreca Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Atreca Inc Files For Mixed Shelf Of Up To $300 Million
Brief: Atreca Presents Data From Ongoing Phase 1B Study Of ATRC-101 In Patients With Select Advanced Solid Tumors During Oral Abstract Session At The ASCO 2023 Annual Meeting
U.S. RESEARCH ROUNDUP-Allakos, Virtu Financial, Walt Disney
Brief: Atreca Reports Qtrly Loss Per Share $0.54
Atreca Inc expected to post a loss of 56 cents a share - Earnings Preview
Brief: Atreca Announces Oral Presentation Of ATRC-101 Phase 1B Study Data At ASCO 2023 Annual Meeting
U.S. RESEARCH ROUNDUP-Globus Medical, Philip Morris, Vail Resorts
U.S. RESEARCH ROUNDUP-Globus Medical, Philip Morris International, Vail Resorts
Brief: Atreca Reports Fourth Quarter Results